Don’t cut funding for cancer research
When Congress resumes work on the fiscal year 2017 budget, it is important that members reject the White House proposal to dramatically reduce funding for cancer research. In fact, it’s vitally important that congressional leaders increase funding to finish work they started to restore critical resources for this lifesaving work.
The proposed reduction to National Institutes of Health funding would be a significant setback for millions of cancer patients, survivors and their families.
We are on the cusp of tremendous breakthroughs in cancer research, making it exactly the wrong moment to turn back the clock on progress against a disease that continues to kill more than 1,650 people a day in this country.
Less than six months ago Congress passed the 21st Century Cures Act. This bill represented lawmakers’ overwhelming bipartisan commitment to the promise and necessity of medical research to our country’s future. Now is the time for Congress to capitalize on that investment rather than reverse course by drastically curtailing National Institutes of Health’s research funding.
As an American Cancer Society Cancer Action Network volunteer, I call on Sens. Heidi Heitkamp and John Hoeven and Rep. Kevin Cramer to vote to increase funding for cancer research in the final 2017 budget.